GeneDx Holdings Corp reports results for the quarter ended June 30 - Earnings Summary

GeneDx Holdings

29/07/2025 14:31

GeneDx Holdings Corp WGS.OQ reported quarterly adjusted earnings of 50 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -10 cents.  The mean expectation of seven analysts for the quarter was for earnings of 10 cents per share. Wall Street expected results to range from 8 cents to 14 cents per share.

Revenue rose 45.6% to $102.69 million from a year ago; analysts expected $85.45 million.

GeneDx Holdings Corp's reported EPS for the quarter was 36 cents​.

The company reported quarterly net income of $10.81 million.

GeneDx Holdings Corp shares had fallen by 8.0% this quarter and gained 10.5% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 36.2% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is also "buy"

Wall Street's median 12-month price target for GeneDx Holdings Corp is $110.00, about 22.8% above its last closing price of $84.91

This summary was machine generated from LSEG data July 29 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
0.10
0.50
Beat
Mar. 31 2025
0.06
0.27
Beat
Dec. 31 2024
0.16
0.62
Beat
Sep. 30 2024
-0.21
0.04
Beat